Constellation Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CNST and buy or sell other stocks, ETFs, and their options commission-free!

About CNST

Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. 

CEO
Jigar Raythatha, MBA
CEOJigar Raythatha, MBA
Employees
Employees
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2008
Founded2008
Employees
Employees

CNST Key Statistics

Market cap
1.63B
Market cap1.63B
Price-Earnings ratio
-11.21
Price-Earnings ratio-11.21
Dividend yield
Dividend yield
Average volume
657.81K
Average volume657.81K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$39.30
52 Week high$39.30
52 Week low
$17.00
52 Week low$17.00

People also own

Based on the portfolios of people who own CNST. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.